The possible role of prolactin in preeclampsia: 2001, a hypothesis revisited a quarter of century later

Medical Hypotheses

Volumn 59, Issue 4, 2002, Pages 378-384

  Parra, A ^a   Ramirez Peredo J ^a  

^a INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; PROLACTIN;

ANGIOGENESIS; ARTERIOLE; ARTERY; CELL INVASION; CHRONOLOGY; CYTOTROPHOBLAST; DEVELOPMENTAL STAGE; DISEASE COURSE; ENDOTHELIUM LESION; GENETIC PREDISPOSITION; HUMAN; HYPOTHESIS; HYPOXIA; IMMUNE RESPONSE; IMMUNOPATHOLOGY; ISCHEMIA; MOLECULAR WEIGHT; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTIN SYNTHESIS; REVIEW; RISK FACTOR; TH1 CELL; TH2 CELL; THEORY; VASCULAR RESISTANCE;

EID: 0036784350     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00124-X     Document Type: Article

References (51)

1. The possible role of prolactin in preeclampsia
2. Maternal plasma and amniotic fluid prolactin levels in normal and hypertensive pregnancy
3. Maternal plasma prolactin levels in preeclampsia
4. Decidual, amniotic fluid, maternal and fetal prolactin in normal and abnormal pregnancies
5. Decreased prolactin secretion by decidual tissue of preeclampsia in vitro
6. Altered prolactin bioactivity in amniotic fluid of hypertensive pregnancy
7. Prolactin in severe toxemia of pregnancy
8. Hypertension and pregnancy-related hypertension
9. Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications
10. A study of angiotensin II pressor response throughout primigravid pregnancy
11. Etiology and pathogenesis of preeclampsia: Current concepts
12. Pathogenesis and genetics of preeclampsia
13. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in preeclampsia
14. A radioimmunoassay for human prolactin
15. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice
16. The comparative endocrinology of prolactin
17. Prolactin: Structure, function and regulation of secretion
18. Extrapituitary prolactin: Distribution, regulation, functions and clinical aspects
19. Gonadotropins, prolactin, inhibin A, inhibin B, and activin A in human fetal serum from midpregnancy and term pregnancy
20. Localization of prolactin and its receptor messenger RNA in the human decidua
21. The relationship between decidualization and prolactin mRNA and production at different stages of human pregnancy
22. Interleukin-2 inhibits the synthesis and release of prolactin from human decidual cells
23. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus
24. Immune neuro-endocrine interactions: Facts and hypothesis
25. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro
26. Rapid modulation of the apoptosis regulatory genes bcl-2 and bax by prolactin in rat Nb2 lymphoma cells
27. Decreased dopaminergic tone and increased basal bioactive prolactin in men with human immunodeficiency virus infection
28. Serum prolactin is associated with apoptosis in men with human immunodeficiency virus infection
29. Modulatory effect of prolactin on the DNA synthesis rate and NK activity of large granular lymphocytes
30. Prolactin variants
31. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins
32. Heterogeneity of serum and amniotic fluid prolactin in humans
33. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and non stimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus
34. The 16-kDa N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
35. A specific high affinity saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells
36. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis
37. Expression of prolactin mRNA and of prolactin-like proteins in endothelial cells: Evidence for autocrine effects
38. Inhibition of exercise-induced blood prolactin response by acute hypoxia
39. 2 breathing increases plasma prolactin
40. Angiogenesis in the human female reproductive tract
41. Oxygen and placental development during the first trimester: Implications for the pathophysiology of preeclampsia
42. Immunologic response in pregnancy
43. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis
44. Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes
45. Increased placental apoptosis in pregnancies complicated by preeclampsia
46. Endothelin-1 in feto-placental tissues from normotensive pregnant women and women with preeclampsia
47. Endothelin inhibits basal and stimulated release of prolactin by human decidual cell
48. Pathogenic implications of interleukin-2 expressed in preeclamptic decidual tissues: A possible mechanism of deranged vasculature of the placenta associated with preeclampsia
49. Proteolytic cleavage confers nitric oxide synthase inducing activity upon prolactin
50. Association of maternal endothelial dysfunction with preeclampsia
51. Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas